摘要
背景:瘦蛋白和胰岛素抵抗在非酒精性脂肪肝(NAFLD)的发病机制中起着重要的作用,越来越多的基因与NAFLD的发病风险有关。 目的:探讨瘦素受体(Lepr)基因多态性(q223r和k109r)与非酒精性脂肪肝(NAFLD)风险之间的遗传关系。 方法:利用PubMed, Web of Science, the Cochrane Library databases, 中国知网 (CNKI) and EMBASE数据库进行检索和整理,用95%置信区间的组合优势比(OR)对遗传关联进行评估。 结果:共对1711例NAFLD患者和1732例健康对照者进行了病例对照研究,在东南亚组等位基因模型中,k109r与NAFLD呈显著正相关(p=0.01,或=0.59,95%Ci[0.39~0.90]),而在中国亚组(p=0.24,或=1.10,95%Ci[0.94~1.29])则无显着性差异(P>0.05)。Q223 R在等位基因和隐性模型中均与NAFLD显著相关(等位基因模型:P<0.001,OR=0.57,95% CI[0.50-0.65);隐性模型:P=0.001,OR=0.67,95% CI [0.2-0.85 ]。亚组分析显示,亚裔人群中Q223和NAFLD在等位基因模型中无显著相关性(P=0.07,OR=0.67,95% CI [52-0.855]。 结论:Lepr k10 9r可能是东南亚人群NAFLD的易感因素,Lepr q2 2 3r可能是中国人群NAFLD的易感因素。
关键词: 瘦素受体,非酒精性脂肪肝,Meta分析,代谢综合征(MS)。
Current Molecular Medicine
Title:The LEPR K109R and Q223R Might Contribute to the Risk of NAFLD: A Meta-Analysis
Volume: 18 Issue: 2
关键词: 瘦素受体,非酒精性脂肪肝,Meta分析,代谢综合征(MS)。
摘要: Background: Leptin and insulin resistance have been pointed out to play a role in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Increasing genes were shown to be associated with the risk of NAFLD.
Objective: The study aimed to investigate the genetic association between two leptin receptor (LEPR) polymorphisms (Q223R and K109R) and the NAFLD risk.
Methods: Studies were retrieved and included by using PubMed, Web of Science, the Cochrane Library databases, Chinese National Knowledge Infrastructure (CNKI) and EMBASE database. Genetic associations were assessed with pooled odds ratios (ORs) with 95% confidence intervals (CIs).
Results: Five case-control studies with 1711 NAFLD patients and 1732 healthy controls were included in this meta-analysis. The K109R was significantly associated with NAFLD in allelic model in Southeast Asian subgroup (p=0.01, OR=0.59, 95% CI [0.39- 0.90]), but not in Chinese subgroup (p=0.24, OR=1.10, 95% CI [0.94-1.29]). The Q223R was significantly associated with NAFLD in both allelic and recessive models (allelic model: p<0.001, OR=0.57, 95% CI [0.50-0.65]; recessive model: p=0.001, OR=0.67, 95% CI [0.52-0.85]). However, subgroup analysis showed that the significant association between Q223R and NAFLD in allelic model cannot be found in Southeast Asians subgroup (p=0.07, OR=0.67, 95% CI [0.52-0.85]).
Conclusion: LEPR K109R might be a susceptible factor for NAFLD in Southeast Asian population. And LEPR Q223R might be a susceptible factor for NAFLD in Chinese population.
Export Options
About this article
Cite this article as:
The LEPR K109R and Q223R Might Contribute to the Risk of NAFLD: A Meta-Analysis, Current Molecular Medicine 2018; 18 (2) . https://dx.doi.org/10.2174/1566524018666180705110412
DOI https://dx.doi.org/10.2174/1566524018666180705110412 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Non Peptidic Urotensin II Antagonists: Perspectives for a New Class of Drugs
Cardiovascular & Hematological Agents in Medicinal Chemistry Sirtuin Family: A Link to Metabolic Signaling and Senescence
Current Medicinal Chemistry Glucagon-like Peptide-1 Receptor Agonists Cardio-protective Effects: An Umbrella Review
Current Diabetes Reviews Insulin Therapy: Going The "Smarter" Way
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Signaling Intermediates (MAPK and PI3K) as Therapeutic Targets in NSCLC
Current Pharmaceutical Design Thalidomide Controls Adipose Tissue Inflammation Associated with High- Fat Diet-Induced Obesity in Mice
Endocrine, Metabolic & Immune Disorders - Drug Targets Pentoxifylline Alleviates Proteinuria in Fructose Model of Metabolic Syndrome
Letters in Drug Design & Discovery The Many Roles of Statins in Ischemic Stroke
Current Neuropharmacology Autophagy and Mitochondria in Obesity and Type 2 Diabetes
Current Diabetes Reviews Inhibition of α-amylase Activity by Zn<sup>2+</sup>: Insights from Spectroscopy and Molecular Dynamics Simulations
Medicinal Chemistry Subject Index to Volume 11
Protein & Peptide Letters Signaling Abnormalities in Systemic Lupus Erythematosus as Potential Drug Targets
Endocrine, Metabolic & Immune Disorders - Drug Targets Effects of Creatine in Skeletal Muscle Cells and in Myoblasts Differentiating Under Normal or Oxidatively Stressing Conditions
Mini-Reviews in Medicinal Chemistry Association of Mean Platelet Volume with Hypertension in Rheumatoid Arthritis
Inflammation & Allergy - Drug Targets (Discontinued) Molecular Mechanisms of Renal Blood Flow Autoregulation
Current Vascular Pharmacology Pulmonary Pathology Among Patients with Type 2 Diabetes Mellitus: An Updated Systematic Review and Meta-analysis
Current Diabetes Reviews Current and Future Prospective of a Versatile Moiety: Imidazole
Current Drug Targets Integrins Modulate Cellular Fibrogenesis at Multiple Levels: Regulation of TGF-β Signaling
Endocrine, Metabolic & Immune Disorders - Drug Targets Vascular and Cellular Calcium in Normal and Hypertensive Pregnancy
Current Clinical Pharmacology Recreational Drug Misuse and Stroke
Current Drug Abuse Reviews